After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$571.96K

Rothblatt Martine A Chairperson & CEO

Transaction date Nov 10, 2026
Public filing date Nov 12, 2026
Filing lag Filed 2 days later

UTHR daily price context

Close on/before transaction
$588.61 Nov 10, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
980 shares @ $583.64
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000186
Filing cohort

Transactions in this filing

Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.69M
Buys / sales
0 / 14
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Nov 10, 2026 $465.52K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $549.7K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $359.94K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $71.06K
United Therapeutics Corp UTHR Exercise Nov 10, 2026 $1.12M
United Therapeutics Corp UTHR Sale Nov 10, 2026 $23.1K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $510.76K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $431.37K
United Therapeutics Corp UTHR Current Sale Nov 10, 2026 $571.96K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $191.8K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $364.54K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $212.09K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $1.2M
United Therapeutics Corp UTHR Sale Nov 10, 2026 $567.32K
United Therapeutics Corp UTHR Sale Nov 10, 2026 $47.43K